Please login to the form below
Emerging Leader
This page shows the latest Emerging Leader news and features for those working in and with pharma, biotech and healthcare.
Syncona launches another cell therapy company, Treg specialist Quell
a company with the potential to be a global leader in this emerging area.”. ... leader in treating conditions of immune dysfunction utilising gene-modified cells.”.
Latest news
-
Twentyeight-Seven raises another $15m for non-coding RNA drugs
This is a different approach to the emerging class of RNA therapeutics that target RNA that is directly involved in protein expression, such as antisense and RNA interference (RNAi) drugs from ... leader in capitalising on the emerging science around RNA
-
NICE recommends MSD’s diabetes drug Steglatro
Lilly and Boehringer Ingelheim’s Jardiance is emerging as the leader in the class, thanks to its strong evidence base, and Lilly increased its share of global revenues by 47% last
-
AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod
Johnson’s Stelara (targeting IL-23 and IL-12) and AbbVie’s own ageing market leader Humira. ... Confident of the drug’s best-in-class status, AbbVie also have underway a head-to-head study with the emerging market leader in the sector, Novartis’
-
Daily Brief: Orchard raises $150m, Astellas swoops for early-stage gene company, Amicus gets FDA Fabry approval
Elise Wang, Principal at Deerfield Management said, “Orchard has made an impressive transition from a start-up company to an emerging leader in gene therapy for rare diseases by building a
-
Sangamo bulks up in cell therapy with TxCell acquisition
We are thrilled to announce this proposed acquisition which would combine TxCell's Treg expertise with our ex vivo gene editing capabilities, positioning Sangamo as a leader in the emerging field
More from news
Approximately 1 fully matching, plus 16 partially matching documents found.
Latest Intelligence
-
Making a difference with medical education
Challenging myself and our team to realise this each day at Lucid is why I come to work,”says Louise Verrall (Business Unit Director), Winner of Comm uniqué Emerging Leader in
-
Pharma deals in February 2015
Together these deals make Mylan a hormonal contraceptives leader in high-growth emerging markets.
-
Interview: Joseph Jimenez, Novartis
The vaccines &diagnostics business is a leader in 'flu, and Novartis' emerging meningitis and pneumococcal franchises will continue to drive growth, Jimenez continues. ... That is why Novartis is expanding its presence in high-growth emerging markets,
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
MSD appoints Jessica Fine as UK external affairs director
She was also highly commended in the Publicis Life Brands Resolute Award for Emerging Leader in Healthcare Communications at last year's Comm uniqué Awards.
-
Douglas Williams named president and CEO of Codiak
We seek to grow Codiak into the leader in this emerging field as we strive to make new, breakthrough medicines that provide significant and lasting patient benefit.”. ... These included serving as chief scientific officer and executive vice president
-
F-star appoints GSK's Neil Brewis
He said: “F-Star is an emerging world leader in bispecfic antibody drug discovery and I am delighted to join the company at this exciting time to help maximise the potential
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Synergy Vision
Advisory boards, slide development and preview meeting, thought-leader management, speaker training and meeting facilitation. ... 2015 Women of the Future Corporate Award Comm uniqué Awards:2014 Sorcha Ferris - Publicis Life Brands Resolute Award
-
Louise Verrall from Lucid Group wins Communiqué 2016 Award for Emerging Leader in Healthcare Communications
From her first degree to her current position as Business Unit Director, Louise has developed a passion for science, education, psychology and entrepreneurialism. She is driven to make a difference in everything she does - for her own curiosity, her
-
Lucid Group shines at the Communiqué Awards
Lucid Group’s commitment to be a leader in medical education was recognised at the Comm uniqué Awards 2016 in London last night, where the agency received three awards, including being ... It heard last night that it had won the ‘Excellence in
-
Bedrock Healthcare Communications
2016 Finalist: Digital Communications: PSLive, Celgene. 2016 Finalist: Emerging Leader in Healthcare Communications: Su Smith, Bedrock.
-
Lucid reach the shortlist for Communiqué 2016 in SIX categories
The Ulcerative Colitis Endoscopic Index of Severity (UCEIS) online tool. Emerging Leader in Healthcare Communications.
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
Featured jobs
- Account Director, Healthcare Communications
-
Salary TBC
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- GSK hires Merck KGaA exec to lead US pharma business
- Novartis chooses internal replacement for US pharma president role
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Senators attack Novartis over 'unconscionable' handling of Zolgensma data
- Boris Johnson announces fast-track immigration plans for top scientists
- Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial
- Blended Intelligence
- Planning a pharma exhibition stand? You must read this!
- Leaked no-deal Brexit document forecasts widespread shortages
- AbbVie scores FDA approval for arthritis treatment upadacitinib
- Novo Nordisk shareholder revolt reaches Europe
- BMS buoyed by FDA approval of Celgene’s myelofibrosis drug
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
Quick links
Infographics
